i am in., page-7

Just watch out here,,,,Pharma manufacturing plant is basically worthless in terms of asset backing,...and that goes for the soil it sits on top of as well. The clean-up costs to dismantle and or sell these assets and certify them as clean far outstrips their value. The US and EU are littered with IDT equivalents that are mothballed due to Chinese and Indian competition.

If I could short this stock I would....you can ask the management at the AGM how or why this company is globally completive....

Labour Cost - NO
Plant and Equipment - NO
Cost of Chemicals, proximity to major chemical supplier - NO
Unique IP with Revenues - NO
Unique IP with probability of making it to market greater than 50% - NO
Geographic Market benefit - NO, Australia is too small a market to supply into

There is more profit in making Pizza....